Lisheng L
Syst.-China, Cardiovascular Institute, Beijing, China.
J Hum Hypertens. 1996 Feb;10 Suppl 1:S9-11.
Syst. China Trial aimed to determine whether titrated antihypertensive treatment could reduce the risk of stroke incidence and other cardiovascular complications among 2,298 older Chinese patients (> or = 60) with isolated systolic hypertension. The data from 3 years follow-up showed that the blood pressure reduction was 7/2 mmHG more in the active treatment group than in the placebo group. Whether this blood pressure reduction results in a clinically meaningful decrease of cardiovascular complications is still under investigation.
中国收缩期高血压试验旨在确定滴定降压治疗是否能降低2298例年龄≥60岁的中国单纯收缩期高血压老年患者中风发病率及其他心血管并发症的风险。3年随访数据显示，积极治疗组的血压降低幅度比安慰剂组多7/2毫米汞柱。这种血压降低是否会导致心血管并发症出现具有临床意义的减少仍在研究中。
